According to Gyre Therapeutics's latest financial reports the company has C$38.03 Million in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2024-12-31 | C$38.27 M | -13.89% |
2023-12-31 | C$44.44 M | 797.31% |
2022-12-31 | C$4.95 M | -6.47% |
2021-12-31 | C$5.29 M |